Excellent discussion on Blood-Based Testing for Surveillance for Colorectal Cancer Is Ready or Not Ready for the Clinic????? 
Key takeaways from #GI25 
✨MRD testing is approved for clinical use in CRC and shows high prognostic value for recurrence.
✨Clinical utility studies are ongoing to refine its role in adjuvant therapy decisions.
✨Challenges remain with ctDNA surveillance, including false positives /negatives and global access issues.
@ASCO  @adasarimd @KristenCiombor @JacquelyneGMD